Cargando…
SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693592/ https://www.ncbi.nlm.nih.gov/pubmed/34937858 http://dx.doi.org/10.1038/s41375-021-01500-1 |
| _version_ | 1784619173806080000 |
|---|---|
| author | Mellinghoff, Sibylle C. Robrecht, Sandra Mayer, Leonie Weskamm, Leonie M. Dahlke, Christine Gruell, Henning Vanshylla, Kanika Schlösser, Hans A. Thelen, Martin Fink, Anna-Maria Fischer, Kirsten Klein, Florian Addo, Marylyn M. Eichhorst, Barbara Hallek, Michael Langerbeins, Petra |
| author_facet | Mellinghoff, Sibylle C. Robrecht, Sandra Mayer, Leonie Weskamm, Leonie M. Dahlke, Christine Gruell, Henning Vanshylla, Kanika Schlösser, Hans A. Thelen, Martin Fink, Anna-Maria Fischer, Kirsten Klein, Florian Addo, Marylyn M. Eichhorst, Barbara Hallek, Michael Langerbeins, Petra |
| author_sort | Mellinghoff, Sibylle C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8693592 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86935922021-12-22 SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia Mellinghoff, Sibylle C. Robrecht, Sandra Mayer, Leonie Weskamm, Leonie M. Dahlke, Christine Gruell, Henning Vanshylla, Kanika Schlösser, Hans A. Thelen, Martin Fink, Anna-Maria Fischer, Kirsten Klein, Florian Addo, Marylyn M. Eichhorst, Barbara Hallek, Michael Langerbeins, Petra Leukemia Letter Nature Publishing Group UK 2021-12-22 2022 /pmc/articles/PMC8693592/ /pubmed/34937858 http://dx.doi.org/10.1038/s41375-021-01500-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Mellinghoff, Sibylle C. Robrecht, Sandra Mayer, Leonie Weskamm, Leonie M. Dahlke, Christine Gruell, Henning Vanshylla, Kanika Schlösser, Hans A. Thelen, Martin Fink, Anna-Maria Fischer, Kirsten Klein, Florian Addo, Marylyn M. Eichhorst, Barbara Hallek, Michael Langerbeins, Petra SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia |
| title | SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia |
| title_full | SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia |
| title_fullStr | SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia |
| title_full_unstemmed | SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia |
| title_short | SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia |
| title_sort | sars-cov-2 specific cellular response following covid-19 vaccination in patients with chronic lymphocytic leukemia |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693592/ https://www.ncbi.nlm.nih.gov/pubmed/34937858 http://dx.doi.org/10.1038/s41375-021-01500-1 |
| work_keys_str_mv | AT mellinghoffsibyllec sarscov2specificcellularresponsefollowingcovid19vaccinationinpatientswithchroniclymphocyticleukemia AT robrechtsandra sarscov2specificcellularresponsefollowingcovid19vaccinationinpatientswithchroniclymphocyticleukemia AT mayerleonie sarscov2specificcellularresponsefollowingcovid19vaccinationinpatientswithchroniclymphocyticleukemia AT weskammleoniem sarscov2specificcellularresponsefollowingcovid19vaccinationinpatientswithchroniclymphocyticleukemia AT dahlkechristine sarscov2specificcellularresponsefollowingcovid19vaccinationinpatientswithchroniclymphocyticleukemia AT gruellhenning sarscov2specificcellularresponsefollowingcovid19vaccinationinpatientswithchroniclymphocyticleukemia AT vanshyllakanika sarscov2specificcellularresponsefollowingcovid19vaccinationinpatientswithchroniclymphocyticleukemia AT schlosserhansa sarscov2specificcellularresponsefollowingcovid19vaccinationinpatientswithchroniclymphocyticleukemia AT thelenmartin sarscov2specificcellularresponsefollowingcovid19vaccinationinpatientswithchroniclymphocyticleukemia AT finkannamaria sarscov2specificcellularresponsefollowingcovid19vaccinationinpatientswithchroniclymphocyticleukemia AT fischerkirsten sarscov2specificcellularresponsefollowingcovid19vaccinationinpatientswithchroniclymphocyticleukemia AT kleinflorian sarscov2specificcellularresponsefollowingcovid19vaccinationinpatientswithchroniclymphocyticleukemia AT addomarylynm sarscov2specificcellularresponsefollowingcovid19vaccinationinpatientswithchroniclymphocyticleukemia AT eichhorstbarbara sarscov2specificcellularresponsefollowingcovid19vaccinationinpatientswithchroniclymphocyticleukemia AT hallekmichael sarscov2specificcellularresponsefollowingcovid19vaccinationinpatientswithchroniclymphocyticleukemia AT langerbeinspetra sarscov2specificcellularresponsefollowingcovid19vaccinationinpatientswithchroniclymphocyticleukemia |